Literature DB >> 7078333

Panendoscopy as a screening examination for simultaneous primary tumors in head and neck cancer: a prospective sequential study and review of the literature.

W F McGuirt.   

Abstract

A prospective panendoscopic evaluation comprising direct laryngoscopy, bronchoscopy, and esophagoscopy was conducted in 100 consecutively seen patients with untreated head and neck primary tumors. Of the patients, 16% (18% counting two third primary lesions found in the 16 patients) had synchronous primary malignant tumors of the serodigestive tract. Eleven of the 16 patients had silent lesions found only by endoscopy, and 6 (6% of the total group) had lesions found only because the full panendoscopic protocol was followed. Those 6 tumors would not have been discovered as early by clinical examination or by symptom-only directed studies. The initial treatment plan in 7 patients was changed by the panenodscopic findings. This study verifies the high incidence of synchronous primary tumors in the head and neck areas that have been reported in retrospective studies, and suggests that an intensive, full panendoscopic work-up as a screening test in all patients with primary head and neck tumors can be conducted without increased morbidity and yields enough information to justify its cost.

Entities:  

Mesh:

Year:  1982        PMID: 7078333     DOI: 10.1288/00005537-198205000-00020

Source DB:  PubMed          Journal:  Laryngoscope        ISSN: 0023-852X            Impact factor:   3.325


  10 in total

Review 1.  Current status of oral cancer treatment strategies: surgical treatments for oral squamous cell carcinoma.

Authors:  Ken Omura
Journal:  Int J Clin Oncol       Date:  2014-04-01       Impact factor: 3.402

2.  Association between hospital case volume and the use of bronchoscopy and esophagoscopy during head and neck cancer diagnostic evaluation.

Authors:  Gordon H Sun; Oluseyi Aliu; Nicholas M Moloci; Joshua K Mondschein; James F Burke; Rodney A Hayward
Journal:  Cancer       Date:  2013-09-24       Impact factor: 6.860

3.  Panendoscopy as a screening procedure for simultaneous primary tumors in head and neck cancer.

Authors:  I J Dhooge; M De Vos; F W Albers; P B Van Cauwenberge
Journal:  Eur Arch Otorhinolaryngol       Date:  1996       Impact factor: 2.503

4.  Panendoscopy and synchronous second primary tumors in head and neck cancer patients.

Authors:  Kimmo Hujala; Jukka Sipilä; Reidar Grenman
Journal:  Eur Arch Otorhinolaryngol       Date:  2004-03-05       Impact factor: 2.503

5.  A rarely observed case of primary multiple carcinomas of the head and neck.

Authors:  D Megighian; P L Zorat
Journal:  Arch Otorhinolaryngol       Date:  1985

6.  Feasibility of salvage endoscopic resection for patients with locoregional failure after definitive radiotherapy for pharyngeal cancer.

Authors:  Hironaga Satake; Tomonori Yano; Yusuke Yoda; Satoshi Fujii; Sadatomo Zenda; Toshifumi Tomioka; Takeshi Shinozaki; Masakazu Miyazaki; Kazuhiro Kaneko; Ryuichi Hayashi
Journal:  Endosc Int Open       Date:  2015-05-26

Review 7.  Surgical errors and risks - the head and neck cancer patient.

Authors:  Ulrich Harréus
Journal:  GMS Curr Top Otorhinolaryngol Head Neck Surg       Date:  2013-12-13

8.  Concomitant Extramedullary Plasmacytoma in the Oropharynx and Hypopharyngeal Squamous Cell Carcinoma.

Authors:  Hiroki Sato; Shoko Yoshimasu; Isaku Okamoto; Akira Shimizu; Yasuaki Katsube; Hideki Tanaka; Kiyoaki Tsukahara
Journal:  Case Rep Otolaryngol       Date:  2018-07-31

9.  Value of oesophagoscopy and bronchoscopy in diagnosis of synchronous malignancies in patients with head and neck squamous cell carcinomas.

Authors:  Shi Yeung Ho; Raymond King Yin Tsang
Journal:  BMC Cancer       Date:  2020-12-01       Impact factor: 4.430

10.  Routine endoscopy for esophageal cancer is suggestive for patients with oral, oropharyngeal and hypopharyngeal cancer.

Authors:  Shih-Han Hung; Ming-Chieh Tsai; Tsai-Ching Liu; Herng-Ching Lin; Shiu-Dong Chung
Journal:  PLoS One       Date:  2013-08-15       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.